Home › Free Stock Grades › OMCL
Omnicell, Inc. (OMCL) Stock Grade
OMCL · Healthcare
B-
Market Cap
$1.5B
P/E Ratio
1014.7
Revenue Growth (YoY)
+6.5%
Net Margin
0.2%
Return on Equity
0.2%
Dividend Yield
None
About Omnicell, Inc.'s fundamentals
Omnicell generates $1.5 billion in market value with revenue growing at 6.5% year-over-year, indicating modest expansion in the healthcare information services market. However, the company's profitability metrics are exceptionally thin, with a net margin of just 0.2% and return on equity of 0.2%, meaning earnings represent a minimal portion of sales and shareholder capital. The extremely elevated P/E ratio of 1014.7 reflects minimal current earnings relative to market valuation. The company does not currently pay a dividend, directing any capital back toward operations or debt reduction.